Scientific Poster
May 03, 2017

Accurate and Reproducible Detection of Fusions and Exon Skipping Events in NSCLC-Derived Samples using a Comprehensive, Targeted RNA-Seq System Across Multiple Laboratories

Scientific Poster, co-authored with Asuragen, from AACR 2017
Targeted RNA-Seq of expression markers in NSCLC FFPE tumors requires integrated reagents, protocols, and interpretive software that can ensure consistent results across laboratories.

Download our poster to learn about this study, where a comprehensive targeted NGS system, the QuantideX® NGS RNA Lung Cancer Kit (RUO)*, was evaluated in 5 laboratories to assess accuracy and reproducibility.

Meet the Authors:
Victor Weigman, Ph.D., Director, Translational Genomics
Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics
Tom Halsey
Dan Su
Maria Curtis

Related Services:
Optimization & Evaluation of SMART-Seq® v4 kit for Low Input RNA Sequencing

An improved strategy for expression profiling via RNA sequencing from limiting amounts of RNA

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

Read More